You are here: goodtoknow, UK - Nov 26, 2008 The National Institute of Clinical Excellence (NICE) has recommended that more women should be offered longer-term contraception in a bid to cut unplanned ...
Women urged to ditch the pill Scotland on Sunday, UK - Nov 8, 2008 By Kate Foster SCOTTISH women will be advised to ditch the contraceptive pill in favour of longer-lasting and more reliable implants and injections, ...
Women on the Pill urged to try newer contraceptives The Herald, UK - Nov 9, 2008 The Scottish Government wants women using the once-revolutionary contraceptive to consider changing to newer, reversible alternatives that are longer-term ...
Action plan to cut Bolton teen pregnancies The Bolton News, UK - Nov 27, 2008 ... encouraging parents to talk to their children more about sex education, and spending more money on making free contraception widely available. ...
Underage pregnancy hotspot to get the jab Peterborough Today, UK - Nov 18, 2008 TEENAGE girls in Peterborough could be offered a controversial contraceptive jab under new Government health plans. It has been revealed that health bosses ...
Long-term contraception urged Nursing in Practice, UK - Nov 11, 2008 The new strategy is expected to be launched by health minister Shona Robison in the spring in a bid to cut the growing number of unwanted pregnancies. ...
Source: Google News
Recent News and Articles on the Keywords: barr + bid + contraceptive Related to the article below (Last Update: 8/5/2008)
Generic drug king Teva to buy Barr in $7.46bln deal AFP - Jul 18, 2008 Barr Pharmaceuticals, Inc. operates in more than 30 countries and has a portfolio of 150 drugs and 70 in development. Its own brand of contraceptives holds ...TEVA - BRL
Teva Bids $9 Billion For Rival Barr Chemical & Engineering News - Jul 23, 2008 Barr's proprietary drug portfolio includes the contraceptives Seasonique and Plan B. "The deal reflects growing opportunities in emerging markets," says ...TEVA - BRL
Business news in brief Philadelphia Inquirer, PA - Jul 17, 2008 Shares of Barr Pharmaceuticals Inc., the maker of contraceptive pills and generic drugs, surged as reports surfaced that it might be acquired by Israeli ...BRL - TEVA
Business Browser Edmonton Journal, Canada - Jul 19, 2008 TORONTO - Bombardier Inc. said Friday it stands behind its bid to replace Toronto's aging streetcar fleet, saying it does not understand complaints from the ...
Source: Google News
[CITATION]Barr CEO Says Amending Plan B Drug Bid S Heavey
[CITATION]Barr Refiles Morning-After Pill Bid, FDA Says T Month, P Months
[CITATION] US Urged to Allow Wider Emergency Contraception L In
[CITATION] FDA Nominee Faces Senators After Plan B Move S Heavey
[CITATION] FDA, Barr to Meet Next Week on Morning-After Pill CME Tracker
Pagination according to issue number AU Blastomyces - American Journal of Epidemiology - Oxford Univ Press ... to Epstein-Barr Virus Cap- Bid Antigen and ... Comparison Groups, Antibodies to
Epstein-Barr Virus Capsid ... Association Be- tween, 233 Contraceptive, Oral, Compounds ...
[CITATION] US FDA Taps Family Doctor for Women's Health Post T Month, P Months
[CITATION] US Senators Drop Objections to FDA Nominee CME Tracker
Physical exam not enough to identify breech births A Options, TOC Latest - 2006 - ingentaconnect.com ...contraception Following the US FDA?s controversial rejection of Barr Pharmaceuticals? bid to make the ?morning after pill? Plan B ? available for ...
Source: Google Scholar
Barr to refile contraceptive bid
Barr Pharmaceuticals Inc. aims to resubmit within two weeks a request to sell its morning-after contraceptive pill without a prescription, the company said on Tuesday, following a meeting with U.S. Food and Drug Administration officials.
The comments come after FDA officials last week agreed to reopen discussions with the drugmaker over their bid to sell the Plan B drug over-the-counter to women ages 16 and older.
The agency has said it should be available without a doctor's order for women 18 and older but kept behind pharmacy counters.
Shares of the drugmaker were up 64 cents, or about 1.3 percent, at $51.29 in afternoon trading on the New York Stock Exchange.
"In response to FDA's comments, Barr intends to have a submission back into the FDA in the next two weeks," Barr spokeswoman Carol Cox told Reuters. She described the meeting with the FDA as "productive."
The company's bid to sell Plan B -- a set of two pills that can prevent pregnancy if taken within 72 hours of sexual intercourse -- without a doctor's note has stirred debate between supporters and critics who have lobbied the agency.
Democrats have also held up Senate confirmation for U.S. President George W. Bush's pick to lead the FDA, Acting FDA Commissioner Andrew von Eschenbach, until the agency makes a final decision on the plan.
